Business Strategies for Sustainable Development: Leveraging Industry 5.0 and Circular Pharmaceutical Supply Chains to Overcome Medicine Waste

IF 12.5 1区管理学 Q1 BUSINESS

Business Strategy and The Environment Pub Date : 2025-02-14 DOI:10.1002/bse.4202

Anguja Agrawal, Aasha Sharma, Bishal Dey Sarkar

{"title":"Business Strategies for Sustainable Development: Leveraging Industry 5.0 and Circular Pharmaceutical Supply Chains to Overcome Medicine Waste","authors":"Anguja Agrawal, Aasha Sharma, Bishal Dey Sarkar","doi":"10.1002/bse.4202","DOIUrl":null,"url":null,"abstract":"Industry 5.0 (I5.0) presents opportunities for streamlining processes, reducing waste, improving resource utilization, and enabling real‐time monitoring and decision‐making in the supply chain. This study proposes a strategy for information‐sharing among pharmaceutical supply chain partners, leveraging I5.0 technologies and circular economy strategies like redistribution of unused medicine to reduce waste. This will enable real‐time demand data sharing throughout the SC, tracking the expiration date, disposal, and redistribution of returned products. The study identifies 10 drivers for the adoption of I5.0 and the circular pharmaceutical supply chain (CPSC) to reduce medicine waste applying a Technology‐Organization‐Environment (TOE) framework in consultation with pharmaceutical supply chain professionals, analyzing their relationships using the Decision‐Making Trial and Evaluation Laboratory (DEMATEL) method. The findings reveal that “recognition of the significance of I5.0” and “government‐supportive policies for circular supply chain and I5.0” are the most influential cause drivers, exerting significant influence on other drivers. Policies such as tax reductions, funding opportunities, and the development of robust digital infrastructure are essential to accelerate adoption. The findings highlight that strengthening these drivers will enhance the adoption of I5.0 and CPSC, thereby reducing medicine waste. This study contributes to the literature in several significant ways by integrating I5.0 and circular supply chain strategies within the pharmaceutical sector to reduce medicine waste, addressing a critical research gap. The proposed framework supports practitioners, policymakers, and industry associations in formulating strategies for adopting I5.0 and CPSC, enabling the reduction of medicine waste and contributing to sustainable development by aligning with environmental goals.","PeriodicalId":9518,"journal":{"name":"Business Strategy and The Environment","volume":"47 1","pages":""},"PeriodicalIF":12.5000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Business Strategy and The Environment","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1002/bse.4202","RegionNum":1,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BUSINESS","Score":null,"Total":0}

引用次数: 0

Abstract

Industry 5.0 (I5.0) presents opportunities for streamlining processes, reducing waste, improving resource utilization, and enabling real‐time monitoring and decision‐making in the supply chain. This study proposes a strategy for information‐sharing among pharmaceutical supply chain partners, leveraging I5.0 technologies and circular economy strategies like redistribution of unused medicine to reduce waste. This will enable real‐time demand data sharing throughout the SC, tracking the expiration date, disposal, and redistribution of returned products. The study identifies 10 drivers for the adoption of I5.0 and the circular pharmaceutical supply chain (CPSC) to reduce medicine waste applying a Technology‐Organization‐Environment (TOE) framework in consultation with pharmaceutical supply chain professionals, analyzing their relationships using the Decision‐Making Trial and Evaluation Laboratory (DEMATEL) method. The findings reveal that “recognition of the significance of I5.0” and “government‐supportive policies for circular supply chain and I5.0” are the most influential cause drivers, exerting significant influence on other drivers. Policies such as tax reductions, funding opportunities, and the development of robust digital infrastructure are essential to accelerate adoption. The findings highlight that strengthening these drivers will enhance the adoption of I5.0 and CPSC, thereby reducing medicine waste. This study contributes to the literature in several significant ways by integrating I5.0 and circular supply chain strategies within the pharmaceutical sector to reduce medicine waste, addressing a critical research gap. The proposed framework supports practitioners, policymakers, and industry associations in formulating strategies for adopting I5.0 and CPSC, enabling the reduction of medicine waste and contributing to sustainable development by aligning with environmental goals.

查看原文本刊更多论文

可持续发展的商业战略：利用工业5.0和循环医药供应链克服药品浪费

工业5.0 （I5.0）为简化流程、减少浪费、提高资源利用率以及在供应链中实现实时监控和决策提供了机会。本研究提出了一种在药品供应链合作伙伴之间进行信息共享的策略，利用I5.0技术和循环经济策略（如重新分配未使用药物）来减少浪费。这将实现整个供应链的实时需求数据共享，跟踪过期日期，处理和重新分配退货产品。该研究确定了采用I5.0和循环药品供应链（CPSC）的10个驱动因素，通过与药品供应链专业人员协商，应用技术-组织-环境（TOE）框架来减少药品浪费，并使用决策试验和评估实验室（DEMATEL）方法分析了它们之间的关系。研究发现，“对I5.0重要性的认识”和“政府对循环供应链和I5.0的支持政策”是影响最大的原因驱动因素，对其他驱动因素具有显著影响。减税、融资机会和发展强大的数字基础设施等政策对于加速采用至关重要。研究结果强调，加强这些驱动因素将促进I5.0和CPSC的采用，从而减少药品浪费。本研究通过整合I5.0和制药行业的循环供应链战略来减少药品浪费，解决了一个关键的研究空白，从而在几个重要方面为文献做出了贡献。建议的框架支持从业者、政策制定者和行业协会制定采用I5.0和CPSC的战略，从而减少药品浪费，并通过与环境目标保持一致，为可持续发展做出贡献。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Business Strategy and The Environment Multiple-

CiteScore

22.50

自引率

19.40%

发文量

336

期刊介绍： Business Strategy and the Environment (BSE) is a leading academic journal focused on business strategies for improving the natural environment. It publishes peer-reviewed research on various topics such as systems and standards, environmental performance, disclosure, eco-innovation, corporate environmental management tools, organizations and management, supply chains, circular economy, governance, green finance, industry sectors, and responses to climate change and other contemporary environmental issues. The journal aims to provide original contributions that enhance the understanding of sustainability in business. Its target audience includes academics, practitioners, business managers, and consultants. However, BSE does not accept papers on corporate social responsibility (CSR), as this topic is covered by its sibling journal Corporate Social Responsibility and Environmental Management. The journal is indexed in several databases and collections such as ABI/INFORM Collection, Agricultural & Environmental Science Database, BIOBASE, Emerald Management Reviews, GeoArchive, Environment Index, GEOBASE, INSPEC, Technology Collection, and Web of Science.